DNA-encoded library (DEL) technology has the potential to revolutionize drug discovery. In the last decade, the technology has become a mainstay within the industry for its unique ability to synthesize and screen up to billions of encoded compounds more efficiently and quickly than traditional methods.1
While we recognize these recent advancements, it is the next generation of DEL technology that we are relentlessly curious about.
Join Johnson & Johnson Innovation – JLABS and Janssen Research & Development as we convene leading scientists to explore the future of DEL technology and its potential to address current limitations within the field.
9:30 AM Opening Remarks
Sanjay Mistry | Regional Head, JLABS San Diego
9:37 AM Janssen R&D Introduction
Jim Edwards | U.S. Head of Discovery Chemistry, Janssen R&D
9:45 AM Scientific Introduction and Presentations
10:55 AM Panel Discussion & Audience Q&A
11:30 AM End of Broadcast